WCM
CELU icon

Weaver Capital Management’s Celularity CELU Stock Holding History

Weaver Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399 Hold
300
– – ﹤0.01% 173
2025
Q4 		$333 Hold
300
– – ﹤0.01% 183
2025
Q3 		$621 Hold
300
– – ﹤0.01% 190
2025
Q2 		$588 Hold
300
– – ﹤0.01% 187
2025
Q1 		$519 Hold
300
– – ﹤0.01% 183
2024
Q4 		$624 Hold
300
– – ﹤0.01% 184
2024
Q3 		$891 Hold
300
– – ﹤0.01% 171
2024
Q2 		$939 Hold
300
– – ﹤0.01% 167
2024
Q1 		$1.57K Buy
+300
New +$1.23K ﹤0.01% 161

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

Weaver Capital Management's CELU Position: Q1 2026 in Review

Weaver Capital Management held its Celularity (CELU) position steady in Q1 2026 at 300 shares worth $399. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Weaver Capital Management first reported a position in CELU in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.57K in Q1 2024. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Weaver Capital Management held 300 shares of Celularity worth $399 as of Q1 2026.
  • Weaver Capital Management left its Celularity share count unchanged in Q1 2026.
  • Celularity made up ﹤0.01% of Weaver Capital Management's portfolio in Q1 2026, its #173 holding.
  • Weaver Capital Management first reported a position in Celularity in Q1 2024 and has held it in 9 quarters since.
  • Weaver Capital Management's Celularity position peaked at $1.57K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Weaver Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.